CCK(B) receptors in the periaqueductal grey are involved in electroacupuncture antinociception in the rat cold water tail-flick test

Neuropharmacology

Volumn 37, Issue 6, 1998, Pages 751-757

  Chen, Xiao Hong ^a   Geller, Ellen B ^a   Adler, Martin W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antagonist; Cholecystokinin; Cold water tail flick; Electroacupuncture; Opioid; Receptor

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; COOLING WATER; DEVAZEPIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROACUPUNCTURE; ELECTROSTIMULATION; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANIMALS; ELECTROACUPUNCTURE; INJECTIONS, INTRAVENTRICULAR; MALE; PAIN THRESHOLD; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLECYSTOKININ; SINCALIDE;

EID: 0031864742     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00028-8     Document Type: Article

References (34)

1. Bock M.G., DiPardo R.M., Evens B.E.et al. Benzodiazepine, gastrin and cholecystokinin receptor ligands: L-365,260. J. Med. Chem. 32:1989;13-19.
2. Chang R.S.L., Lotti V.J. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist. Proc. Natl. Acad. Sci. USA. 83:1986;4923-4926.
3. Chen X.H., Han J.-S. All three types of opioid receptors in the spinal cord are important for 2/15 Hz electroacupuncture analgesia. Eur. J. Pharmacol. 211:1992;203-210.
4. Chen X.H., Han J.-S. Analgesia induced by electroacupuncture of different frequencies is mediated by different types of opioid receptors: another cross-tolerance study. Behav. Brain Res. 47:1992;143-149.
5. Chen X.H., Geller E.B., Sterling G.H., McCafferty M.R., Adler M.W., 1994a. Increase of cholecystokinin-octapeptide (CCK-8) release in the periaqueductal grey (PAG) in electroacupuncture (EA) analgesia in rats. 13th Annu. Sci. Meet. of the American Pain Society, Miami Beach, FL, 10-13 November 1994, pp. A-33 (Abstract).
6. Chen X.H., Han J.-S., Huang L.-T. CCK receptor antagonist L-365,260 potentiated electroacupuncture analgesia in Wistar rats but not in audiogenic epileptic rats. Chin. Med. J. 107:1994;113-118.
7. Chen X.H., Geller E.B., Adler M.W. Electrical stimulation at traditional acupuncture sites in periphery produces brain opioid-receptor-mediated antinociception in rats. J. Pharmacol. Exp. Ther. 277:1996;654-660.
8. Ding X.Z., Fan S.G., Han J.-S. Blockade of morphine analgesia by intracerebroventricular or subarachnoid injections of cholecystokinin in rats. Acta Pharmacol. Sin. 6:1985;241-244.
9. Ding X.Z., Fan S.G., Zhou Z.F., Han J.-S. Reversal of tolerance to morphine but no potentiation of morphine-induced analgesia by antiserum against cholecystokinin octapeptide. Neuropharmacology. 25:1986;1155-1160.
10. Dourish C.T., Hill D.R. Classification and function of CCK receptors. Trends Pharmacol. Sci. 8:1987;207-208.
11. Dourish C.T., Hawley D., Iversen S.D. Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718. Eur. J. Pharmacol. 147:1988;469-472.
12. Dourish C.T., O'Neill M.F., Coughlan J., Kitchener S.J., Hawley D., Iversen S.D. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur. J. Pharmacol. 176:1990;35-44.
13. Faris P.L., Komisaruk B.R., Watkins L.R., Mayer D.J. Evidence for the neuropeptide cholecytokinin as an antagonist of opiate analgesia. Science. 219:1983;310-312.
14. Fei H., Xie G.X., Han J.S. Differential release of met-enkephalin and dynorphin in spinal cord by electroacupuncture of different frequencies. Chin. Sci. Bull. 32:1987;1496-1501.
15. Fei H., Sun S.-L., Han J.S. New evidence supporting differential release of enkephalin and dynorphin by low and high frequency electroacupuncture stimulation. Chin. Sci. Bull. 33:1988;703-705.
16. Ghosh S., Geller E.B., Adler M.W. Interaction of cholecystokinin and somatostatin with a selective μ-opioid agonist and μ- and κ-antagonists in thermoregulation. Brain Res. 745:1997;152-157.
17. Han J.S., Ding X.Z., Fan S.G. Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous antiopioid substrates? Neuropeptides. 5:1985;399-402.
18. Han J.-S., Ding X.-Z., Fan S.-G. The frequency as the cardinal determinant for electroacupuncture analgesia to be reversed by opioid antagonists. Acta Physiol. Sin. 38:1986;475-482.
19. Han J.-S., Ding X.Z., Fan S.-G. Cholecystokinin octapeptide (CCK-8): antagonism to electroacupuncture analgesia and a possible role in electroacupuncture tolerance. Pain. 27:1986;101-108.
20. Hill D.R., Campbell N.J., Shaw T.M., Woodruff G.N. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonist. J. Neurosci. 7:1987;2967-2976.
21. Hill R.G., Hughes J., Pittaway K.M. Antinociceptive action of cholecystokinin octapeptide (CCK-8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors. Neuropharmacology. 26:1987;289-300.
22. Mayer D.J., Price D.D., Rafii A. Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone. Brain Res. 121:1977;368-372.
23. Moran T., Robinson P.H., Goldrich M.S., McHugh P.R. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res. 362:1986;175-179.
24. Pellegrino L.J., Cushman A.J., 1967. A Stereotaxic Atlas of the Rat Brain. Appleton-Century-Crofts, New York.
25. Pizziketti R.J., Pressman N.S., Geller E.B., Cowan A., Adler M.W. Rat cold water tail-flick: a novel analgesic test that distinguishes opioid agonists from mixed agonist-antagonists. Eur. J. Pharmacol. 119:1985;23-29.
26. Pomeranz B., Chiu D. Naloxone blockade of acupuncture analgesia: endorphin implicated. Life Sci. 19:1976;1757-1762.
27. Rattray M., Savery D., Wotherspoon G., Priestley J.V., Smith G. Two populations of cells that express preprocholecystokinin mRNA in ventral periaqueductal grey. Neurosci. Lett. 143:1992;55-59.
28. Vanderhaeghen J.J., Signeau J.C., Gepts W. New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature. 257:1975;604-605.
29. Wang X.J., Han J.S. Modification by cholecystokinin-8 of binding of the mu, delta and kappa opioid receptors. J. Neurochem. 55:1990;1379-1382.
30. Wang X.J., Wang X.H., Han J.S. Cholecystokinin octapeptide antagonized opioid analgesia mediated by μ- and κ- but not δ-receptors in the spinal cord of the rat. Brain Res. 523:1990;5-10.
31. Wiesenfeld-Hallin Z., Xu X.-J., Hughes J., Horwell D.C., Hokfelt T. PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. Proc. Natl. Acad. Sci. USA. 87:1990;7105-7109.
32. Woodruff G.N., Hughes J. Cholecystokinin antagonists. Annu. Rev. Pharmacol. Toxicol. 31:1991;469-501.
33. Xie G.-X., Han J.-S. Analgesia produced by electroacupuncture of different frequencies is mediated by different varieties of opioids in the spinal cord. Chin. Sci. Bull. 30:1985;385-391.
34. Zhou Y., Sun Y.H., Shen J.M., Han J.S. Increased release of immunoreactive CCK-8 by electroacupuncture and enhancement of electroacupuncture analgesia by CCK-B antagonist in rat spinal cord. Neuropeptides. 24:1993;139-144.